Eudaimonia Partners’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $142K | Buy |
+10,434
| New | +$142K | 0.03% | 253 |
|
|
2023
Q1 | – | Sell |
-13,790
| Closed | -$196K | – | 363 |
|
|
2022
Q4 | $196K | Buy |
13,790
+548
| +4% | +$7.79K | 0.05% | 321 |
|
|
2022
Q3 | $181K | Buy |
13,242
+1,477
| +13% | +$20.2K | 0.05% | 319 |
|
|
2022
Q2 | $167K | Sell |
11,765
-263
| -2% | -$3.73K | 0.03% | 370 |
|
|
2022
Q1 | $199K | Buy |
+12,028
| New | +$199K | 0.03% | 384 |
|
|
2021
Q2 | – | Sell |
-6,729
| Closed | -$133K | – | 802 |
|
|
2021
Q1 | $133K | Sell |
6,729
-723
| -10% | -$14.3K | 0.03% | 412 |
|
|
2020
Q4 | $147K | Buy |
7,452
+142
| +2% | +$2.8K | 0.03% | 356 |
|
|
2020
Q3 | $129K | Buy |
7,310
+165
| +2% | +$2.91K | 0.03% | 350 |
|
|
2020
Q2 | $128K | Buy |
7,145
+127
| +2% | +$2.28K | 0.05% | 309 |
|
|
2020
Q1 | $105K | Sell |
7,018
-11,273
| -62% | -$169K | 0.05% | 321 |
|
|
2019
Q4 | $319K | Buy |
+18,291
| New | +$319K | 0.13% | 182 |
|